Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

Griveau A, Seano G, Shelton SJ, Kupp R, Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, Tien AC, Sabo JK, Wang N, Chen I, Kloepper J, Larrouquere L, Ghosh M, Tirosh I, Huillard E, Alvarez-Buylla A, Oldham MC, Persson AI, Weiss WA, Batchelor TT, Stemmer-Rachamimov A, Suvà ML, Phillips JJ, Aghi MK, Mehta S, Jain RK, Rowitch DH.

Cancer Cell. 2018 May 14;33(5):874-889.e7. doi: 10.1016/j.ccell.2018.03.020. Epub 2018 Apr 19.

2.

Olig1 is required for noggin-induced neonatal myelin repair.

Sabo JK, Heine V, Silbereis JC, Schirmer L, Levison SW, Rowitch DH.

Ann Neurol. 2017 Apr;81(4):560-571. doi: 10.1002/ana.24907.

3.

Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes.

Staahl BT, Benekareddy M, Coulon-Bainier C, Banfal AA, Floor SN, Sabo JK, Urnes C, Munares GA, Ghosh A, Doudna JA.

Nat Biotechnol. 2017 May;35(5):431-434. doi: 10.1038/nbt.3806. Epub 2017 Feb 13.

PMID:
28191903
4.

Oligodendroglial maturation is dependent on intracellular protein shuttling.

Göttle P, Sabo JK, Heinen A, Venables G, Torres K, Tzekova N, Parras CM, Kremer D, Hartung HP, Cate HS, Küry P.

J Neurosci. 2015 Jan 21;35(3):906-19. doi: 10.1523/JNEUROSCI.1423-14.2015.

5.

Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair.

Sabo JK, Aumann TD, Kilpatrick TJ, Cate HS.

PLoS One. 2013 May 1;8(5):e63415. doi: 10.1371/journal.pone.0063415. Print 2013.

6.

Signalling pathways that inhibit the capacity of precursor cells for myelin repair.

Sabo JK, Cate HS.

Int J Mol Sci. 2013 Jan 7;14(1):1031-49. doi: 10.3390/ijms14011031. Review.

7.

Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation.

Wu M, Hernandez M, Shen S, Sabo JK, Kelkar D, Wang J, O'Leary R, Phillips GR, Cate HS, Casaccia P.

J Neurosci. 2012 May 9;32(19):6651-64. doi: 10.1523/JNEUROSCI.4876-11.2012.

8.

Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions.

Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS.

J Neurosci. 2011 Mar 23;31(12):4504-10. doi: 10.1523/JNEUROSCI.5859-10.2011.

9.

Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues.

Lee EF, Yao S, Sabo JK, Fairlie WD, Stevenson RA, Harris KS, Anders RF, Foley M, Norton RS.

Biopolymers. 2011 May;95(5):354-64. doi: 10.1002/bip.21582. Epub 2011 Jan 6.

10.

Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination.

Cate HS, Sabo JK, Merlo D, Kemper D, Aumann TD, Robinson J, Merson TD, Emery B, Perreau VM, Kilpatrick TJ.

J Neurochem. 2010 Oct;115(1):11-22. doi: 10.1111/j.1471-4159.2010.06660.x.

11.

Effects of bone morphogenic proteins on neural precursor cells and regulation during central nervous system injury.

Sabo JK, Kilpatrick TJ, Cate HS.

Neurosignals. 2009;17(4):255-64. doi: 10.1159/000231892. Epub 2009 Sep 30. Review.

12.
13.

Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.

Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M.

J Biol Chem. 2009 Apr 3;284(14):9361-71. doi: 10.1074/jbc.M808762200. Epub 2009 Jan 21.

14.

The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.

Babon JJ, Sabo JK, Soetopo A, Yao S, Bailey MF, Zhang JG, Nicola NA, Norton RS.

J Mol Biol. 2008 Sep 12;381(4):928-40. doi: 10.1016/j.jmb.2008.06.038. Epub 2008 Jun 20.

15.

The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.

Beeton C, Smith BJ, Sabo JK, Crossley G, Nugent D, Khaytin I, Chi V, Chandy KG, Pennington MW, Norton RS.

J Biol Chem. 2008 Jan 11;283(2):988-97. Epub 2007 Nov 5.

16.

Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain.

Low A, Chandrashekaran IR, Adda CG, Yao S, Sabo JK, Zhang X, Soetopo A, Anders RF, Norton RS.

Biopolymers. 2007 Sep;87(1):12-22.

PMID:
17516503
17.

Solution structure and alanine scan of a spider toxin that affects the activation of mammalian voltage-gated sodium channels.

Corzo G, Sabo JK, Bosmans F, Billen B, Villegas E, Tytgat J, Norton RS.

J Biol Chem. 2007 Feb 16;282(7):4643-52. Epub 2006 Dec 5.

18.

Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue.

Sabo JK, Keizer DW, Feng ZP, Casey JL, Parisi K, Coley AM, Foley M, Norton RS.

Infect Immun. 2007 Jan;75(1):61-73. Epub 2006 Oct 23.

19.

Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.

Drechsler A, Potrich C, Sabo JK, Frisanco M, Guella G, Dalla Serra M, Anderluh G, Separovic F, Norton RS.

Biochemistry. 2006 Feb 14;45(6):1818-28.

PMID:
16460028
20.

Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1.

Harris KS, Casey JL, Coley AM, Masciantonio R, Sabo JK, Keizer DW, Lee EF, McMahon A, Norton RS, Anders RF, Foley M.

Infect Immun. 2005 Oct;73(10):6981-9.

Supplemental Content

Support Center